-
-
Administers Grant
-
18-0006 Mod 6 (EA)
-
A 52-Week, Multicenter, Phase 1 Open-label Study to Evaluate the Safety of LX1001 in Participants with APOE4 Homozygote Alzheimers Disease
-
A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-dose Study of MG01CI (Metadoxine Extended-Release) 700 Mg and 1400 Mg Compared with Placebo in Adults and Adolescents with Fragile X Syndrome
-
A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety
-
A Multicenter, Open-Label Study Evaluating the Long-Term Safety, and Tolerability, and Efficacy of Monthly Subcutaneous Administration of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Pediatric Patients 6 to 17 Years
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventative Treatment of Episodic Migraine in Pe
-
A Multicenter, Randomized, DoubleBlind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment
of Chronic Migraine in Pedia
-
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3200327 in Subjects with Active Sjögren¿s Syndrome
-
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases
-
A Phase 2 Open-Label Trial to Assess the Efficacy and Safety of KRN23, an Antibody to FGF23, in Subjects with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
-
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and
-
A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of MEDI6012 in Subjects with Stable Coronary Artery Disease
-
A Phase 2b, Open-Label, Long-Term Extension Study to Evaluate the Safety and Pharmacodynamics of KRN23 in Adult Subjects with X-Linked Hypophosphatemia (XLH)
-
A Phase 3, Placebo Controlled, Randomized, Observer-Blinded Study to Evaluate the Efficacy, Safety, and Tolerability of a Clostridium Difficile Vaccine in Adults 50 Years of Age and Older
-
A Phase 3, Randomized, Multicenter, Multinational, Double-Blinded Study Comparing the Efficacy and Safety of Repeated Bi-Weekly Infusions ff neoGAA (GZ402666) and Alglucosidase Alfa in Treatment Naive Patients With Late Onset Pompe Disease"
-
A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokinetics, Efficacy, Safety, Tolerability, and Immunogenicity of Multiple Subcutaneous Injections of Efg
-
A Phase III Randomized, Observer-Blind, Placebo-Controlled Study to Demonstrate the Efficicay of Respiratory Syncytical Virus (RSV) Recombinant F Nanoparticale Vaccine in Prevention of Acute, Symptomatic RSV-Associated Respiratory Disease, and Acute
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of
KRN23 in Adult Patients with X-linked Hypophosphatemia (XLH)¿
-
A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients with Type 2 Diabetes Mellitus
-
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication
-
A Study of the Efficacy and Safety of Guselkumab in Participants
with Moderately to Severely Active Ulcerative Colitis
-
A randomized, double-blind, placebo-controlled, parallel group 26-week dose-investigating study to explore the pharmacokinetics, pharmacodynamic effects, efficacy, safety and tolerability of RO5186582 in children with Down syndrome aged 6-11 years.
-
AHEC Primary Care / ORPCE FY17
-
AHEC Primary Care / ORPCE FY18
-
AHEC Primary Care Initiative / ORPCE FY16
-
AHEC COMPOSITE FY20
-
AHEC COMPOSITE FY22
-
AHEC Composite FY16
-
AHEC Composite FY17
-
AHEC Composite FY18
-
AHEC Composite FY19
-
AHEC Health Careers & Work Force Diversity FY15
-
AHEC Health Careers & Workforce Diversity FY16
-
AHEC Health Careers / Model State-Supported AHEC Grant FY20
-
AHEC Health Careers / Point of Service Maint & Enhancement FY18
-
AHEC Health Careers / Point of Service Maint & Enhancement FY19
-
AHEC Health Careers / Point of Service Maintenance & Enhancement FY17
-
AHEC MSSAG / HEALTH CAREERS FY21
-
AHEC MSSAG / HEALTH CAREERS FY22
-
AHEC Mental Health FY16
-
AHEC Mental Health FY17
-
AHEC Mental Health FY18
-
AHEC Operations Composite FY15
-
AHEC RESIDENCY SUPPORT FY21
-
AHEC RESIDENCY SUPPORT FY22
-
AHEC Residency Support FY15
-
AHEC Residency Support FY16
-
AHEC Residency Support FY17
-
AHEC Residency Support FY18
-
AHEC Residency Support FY19
-
AHEC Residency Support FY20
-
Affecting Culture Change: Building Unit-Level Infrastructure to Mitigate Research Integrity Risk
-
An Activatable Nanoparticle Probe for Molecular Imaging of Protease Activity by Dual Energy CT
-
An Ascending, Single and Multiple Dose(s), Double-Blind, Randomized, Placebo Controlled Study Assessing the Safety, Tolerability, and Pharmacokinetics of OV329 in Healthy Male and Female Participants
-
An Exploratory Phase II Study to Determine the Safety, Tolerability, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Adults with DSM-5 Intermittent Explosive Disorder (IED)
-
An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults with X-Linked Hypophosphatemia (XLH)
-
Animal Housing And Maintenance : Rfp 273-94-P-0004
-
Asfaw - IPA
-
Assessing Use of Acoustic Radiation Force to Noninvasively Measure Liver Pressure
-
B43541003 Type 1 Diabetes Phase I Study
-
BMS CV202-010-0055
-
Biological Role And Mechanism Of Action Of Nef
-
Biological Roles And Mechanism Of Action Of Nef
-
Building Opportunities and Overtures in Science and Technology
-
Bundled Testing and Patient navigation
-
COMBINE - ARLG 2.0 - DEPRU Site Budget (Yr8 of ARLG/Yr1 of ARLG 2.0)
-
Caldwell IPA
-
Cannady--Atlanta IPA
-
Cardiac Filling Pressure Estimation with a Non-Invasive Device (Pufferfish)
-
Characterization of the role of Din7 in mitochondrial DNA replication and genome integrity in the yeast Saccharomyces cerevisiae
-
Cloning Of Hereditary Hemorrhagic Telangiectasia Gene
-
Cloning The Hereditary Hemorrhagic Telangiectasia Gene
-
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
-
Creation of a Secured IRB Protocol Management System
-
Deep learning for prognostication in breast cancer
-
Defining the cellular target of radiotherapy in primary mouse models of cancer
-
Digital Device Library
-
Display Memory Mutant Repressors Of Hiv Replication
-
Dissecting the role of ATRX in soft tissue sarcoma development and radiation response
-
Dissecting the roles of HIF-1a and HIF-2a in tumor response to radiation therapy
-
Diversity Of Tgf Beta Receptor Mutations In Hht Syndrome
-
Drake-Atlanta IPA
-
Duke BioCoRE: Increasing Diversity through Student and Faculty Engagement
-
DukeMed Activated
-
EPCTU - Task Area A - Admin and Overall
-
Economic Evaluation and Research Prioritization of Adult Hearing Screening in the US
-
Endothelial Cell Lineage Studies in Cerebral Cavernous Malformations
-
Enhancing Duke University's Animal Resources
-
Enhancing a culture of inclusiveness and support for minority scientists and faculty through the Duke BioCoRE Program
-
Enhancing dendritic cell migration to drive potent anti-tumor immune responses
-
Evaluation of GIMate Handheld Hydrogen Breath Monitor for Diagnosis of Lactose Malabsorption
-
Evaluation of the iMOST X Morphology Flagging
-
Expansion of Animal Resources for Large Animals (Vivarium Expansion project)
-
Fibroblast Growth Factor Homologous Factor Modulation and Effect on Cardiac Ion Channel Trafficking
-
First-in-human (FIH) Safety and Dose Ranging Study of TT-034 in Patients with Chronic Hepatitis C (CHC) Infection
-
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
-
Fund to Retain Clinical Scientists at Duke
-
GCRC - Uterine Longitudinal Leiomyoma Intervention Study
-
GS-US-326-1100 Dr. Onken Study
-
Gcrc-Cap-Michael Morse
-
General Clinical Research Center
-
General Clinical Research Center
-
Gertrude B. Elion Mentored Medical Student Award
-
Gertrude B. Elion Mentored Medical Student Award
-
Gertrude B. Elion Mentored Medical Student Award
-
Gertrude B. Elion Mentored Medical Student Award
-
Gertrude Elion Mentored Medical Research Award
-
Gertude B. Elion Mentored Medical Research Award
-
Get Data @ Duke
-
Glucose Metabolism and p53 in Leukemia
-
HIV Early Intervention Testing
-
Healthy Volunteer Study of CSF fluid and Oral Bioavailability of RR-HNK
-
Housing Opportunities for Persons with AIDS
-
Housing Opportunities for Persons with AIDS
-
Humoral And Cellular Mediators Of Inflammation
-
IPA, Thomas Skeuse
-
IPA--Katie Clikscales
-
IPA-Connor Drake
-
Immune Correlates of Protection Against Congenital Cytomegalovirus Transmission in an HIV-Infected Mother-Infant Cohort
-
Immunosuppressant Targets In Cryptococcus Neoformans
-
Improving the Bryan Vivarium in Support of the Rodent Imaging Core
-
Integrated Human Research Subjects Protection Project
-
Interneuron Synapses: In Vivo Chemicogenetic Proteomics to Discover Developmental Brain Disorder Etiologies
-
Investigating the Metabolic Reprogramming of Ovarian Tumors During Omental Metastasis
-
MIP1404-1301
-
MYK-461-001 Hypertrophic Cardiomyopathy and Healthy Volunteers
-
MYK-461-019 (EMBARK)
-
Mechanism Of Action Of The Hiv-1 Rev Gene Product
-
Medical Scientist Training Program
-
Medical Scientist Training Program
-
NBME OSCE for Clinical Reasoning Creative Community
-
Novel Antifungal Drug Targets In Cryptococcus Neoformans
-
Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse
-
P1CTU Protocol Development for 17-0033 (Base)
-
P1CTU_Task Order 16_Protocol Implementation (Mod 3)
-
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT AND CONCEPT DEVELOPMENT TASK AREA A TASK ORDER.
-
PTN2: Trial Designs for Dosing/Safety and Efficacy in Pediatric Therapeutics_TO5; PTN-TBS02, Adult Terbutaline - DUK99
-
Pediatric Scientist Development Program (K12)
-
Pediatric Scientist Development Program (March of Dimes)
-
Phase 1 Clinical Trials for Development of Neurotherapeutics Performance
-
Phase 2 Study of Efficacy, Safety and Tolerability of R05186582 in Adults with Adolescents with Down Syndrome (Clematis)
-
Phase 3 BMN 701 in rhGAA Exposed Subjects with Late-Onset Pompe Disease
-
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized
-
Phase I Open Label Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults
-
Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine
-
Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects.
-
Physician Scientist Development Program
-
Preclinical Development of Novel HSP90 Inhibitors for the Prevention and Treatment of Chikungunya Virus Infections
-
Program to Support Student Development and Diversity in Duke Biosciences
-
Protective role of dectin-1 signaling in an animal model of Multiple Sclerosis
-
RTOP 18-0006 Base / Protocol Development
-
RTOP 18-0006 Option 1 / Protocol Implementation
-
RTOP 18-0006 Option 1 / Protocol Implementation
-
RTOP 18-0006 Option 1 Mod 5
-
Role of hedgehog signaling in tumor-associated macrophage polarization
-
Ryan White Part B Region 7 Network of Care
-
Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in
Healthy Normal Subjects
-
Same
-
Same
-
Same
-
Same
-
Sanofi NeoGAA
-
Save a Life Public Education Event
-
Scholarships For Students Of Exceptional Financial Need
-
School of Medicine 2017 Biddle
-
School of Medicine 2020 Biddle
-
School of Medicine 2021 Biddle
-
School of Medicine 2022 Biddle
-
Scientific Outreach and Community Engagement by Diverse Scientists in the Duke University Office Biomedical Graduate Diversity
-
Structural Determination of Novel GPCR Signaling Complexes that Mediate Sustained G Protein Signaling
-
Studying Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors
-
TASK AREA A, TASK ORDER FY.2018.A1.0095 Task Area A
-
TDE Pickett Road Infrastructure
-
Targeting EGFRvIII in Brain Tumors with Bispecific Antibodies
-
The Follow Up Study Regarding the Safety and Efficacy of TT-034, a Genetically-Modified Adeno-Associated Virus Designed to Target Hepatitis C in a Study Under Protocol B2801001.
-
The Genetics Of Hereditary Hemorrhagic Telangiectasia
-
To assess the safety and tolerability of single agent RP1 in selected organ transplant recipients
-
Trans-Dominant Mutant Repressors Of Hiv-1 Replication
-
VLZ-MD-21
-
What Matters in Mentoring: Effect of Mentor Cultural Awareness on Mentee Outcomes
R01-GM094573 (Pls: Byars-Winston, Pfund)
-
same
-
Sub-Organizations